Studies have shown that the presence of the epithelial cell adhesion molecule (EpCAM) in exosomes has diagnostic value for colorectal cancer, while other markers in exosomes such as the EGFR subtypes can predict the efficacy of treatments for glioblastoma [40,41,42,43]. Here, EPCAM is linked to glioblastoma.